Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more
Wanbury Limited (WANBURY) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.053x
Based on the latest financial reports, Wanbury Limited (WANBURY) has a cash flow conversion efficiency ratio of -0.053x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹-56.53 Million) by net assets (₹1.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wanbury Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Wanbury Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Wanbury Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wanbury Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Haivision Systems Inc
PINK:HAIVF
|
0.127x |
|
Ofuna Technology Co., Ltd.
TWO:4577
|
0.049x |
|
Comstock Holding Companies Inc
NASDAQ:CHCI
|
-0.057x |
|
STV GROUP PLC LS -50
F:3YC
|
N/A |
|
Bygg Partner i Dalarna Holding AB
ST:BYGGP
|
0.329x |
|
Wir Asia Tbk PT
JK:WIRG
|
0.022x |
|
QUADPACK INDUSTRIES EO 1
F:4VP
|
N/A |
|
Independent Bond
CO:IIVBON
|
N/A |
Annual Cash Flow Conversion Efficiency for Wanbury Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Wanbury Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹592.72 Million | ₹261.02 Million | 0.440x | +209.30% |
| 2024-03-31 | ₹279.41 Million | ₹39.78 Million | 0.142x | +123.60% |
| 2023-03-31 | ₹-328.16 Million | ₹197.97 Million | -0.603x | +65.13% |
| 2022-03-31 | ₹-234.20 Million | ₹405.23 Million | -1.730x | -1520.63% |
| 2021-03-31 | ₹-1.56 Billion | ₹166.81 Million | -0.107x | +65.30% |
| 2020-03-31 | ₹-1.43 Billion | ₹441.33 Million | -0.308x | -116.56% |
| 2019-03-31 | ₹-2.09 Billion | ₹297.31 Million | -0.142x | +18.93% |
| 2018-03-31 | ₹-1.85 Billion | ₹323.65 Million | -0.175x | +38.09% |
| 2017-03-31 | ₹-1.53 Billion | ₹433.86 Million | -0.283x | -7.32% |
| 2016-03-31 | ₹-1.63 Billion | ₹430.53 Million | -0.264x | -16.35% |
| 2015-03-31 | ₹-1.77 Billion | ₹401.67 Million | -0.227x | +17.67% |
| 2014-03-31 | ₹-1.65 Billion | ₹454.48 Million | -0.275x | +92.09% |
| 2013-03-31 | ₹-212.95 Million | ₹741.21 Million | -3.481x | -980.07% |
| 2012-03-31 | ₹711.13 Million | ₹281.25 Million | 0.395x | +747.00% |
| 2011-03-31 | ₹1.05 Billion | ₹49.02 Million | 0.047x | -78.40% |
| 2010-03-31 | ₹1.92 Billion | ₹416.05 Million | 0.216x | -52.49% |
| 2009-03-31 | ₹1.58 Billion | ₹720.95 Million | 0.455x | +318.55% |
| 2007-03-31 | ₹1.29 Billion | ₹-268.83 Million | -0.208x | -346.01% |
| 2006-03-31 | ₹1.01 Billion | ₹-47.21 Million | -0.047x | -- |